Showing 31-38 of 38 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D | The Governing Council of the University of Toronto | Xiao Yu (Shirley) Wu | Cures | 01-April-2023 to 31-March-2027 | $899,710.00 |
| Regenerating Human Pancreatic β Cells to Treat Diabetes | Sunnybrook Research Institute | Robert Screaton | Cures | 01-May-2022 to 31-May-2026 | $900,000.00 |
| Targeting Novel GPCRs to Promote Beta Cell Survival | Sunnybrook Research Institute | Robert Screaton | Cures | 01-February-2022 to 28-February-2026 | $110,000.00 |
| Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus | Sinai Health System | Andras Nagy | Cures | 01-October-2022 to 30-September-2026 | $1,474,390.51 |
| A Novel, Dual-Hormone, Fully Automated Artificial Pancreas for Type 1 Diabetes | McGill University | Ahmad Haidar | Improving Lives | 01-October-2021 to 01-January-2026 | $899,952.00 |
| Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D | Integrated Nanotherapeutics, Inc | Chris Tam | Cures | 01-June-2024 to 30-November-2026 | $750,000.00 |
| Development of a trans-ancestral genetic risk score for type 1 diabetes | Centre hospitalier universitaire Sainte-Justine | Despoina Manousaki | Cures | 01-August-2022 to 31-July-2025 | $577,621.93 |
| A combined chemical synthetic / intravital imaging approach to explore the survival and function of human pluripotent derived islets after transplantation in mice. | Centre hospitalier de l’Universite de Montreal (CHUM) | Guy Rutter | Cures | 01-April-2025 to 31-March-2027 | $599,959.77 |